Literature DB >> 23134583

Oxidized LDL receptor 1 gene polymorphism in patients with metabolic syndrome.

Vincenzo O Palmieri1, Brigida Coppola, Ignazio Grattagliano, Valentina Casieri, Giovanna Cardinale, Piero Portincasa, Giuseppe Palasciano, Francesca Di Serio.   

Abstract

AIMS: The lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1), encoded by the OLR1 gene, has been implicated in the pathogenesis of atherosclerosis. We therefore evaluated the genotyping of OLR1 gene in a sample of 55 patients with Metabolic Syndrome, a clinical condition characterized by a high cardiovascular risk. METHODS AND PATIENTS: The genotyping of the LOX-1 was performed by polymerase chain reaction (PCR) analysis of the IVS4-14 A>G OLR1 polymorphism embedded within the OLR1 Linkage Disequilibrium block. Patients were assessed for routine serum parameters, microalbuminuria, insulin resistance (HOMA) and oxidative stress (thiobarbituric acid reactive substances, TBARs and thioredoxin).
RESULTS: The allele or genotype distribution of the OLR1 IVS4-14 A>G was not statistically different between MS and controls subjects. A positive association was found between IVS4-14 GG genotype, microalbuminuria and fasting glycaemia as well as a higher frequency of type 2 diabetes, elevated microalbuminuria, fasting serum glucose and HOMA index in the same subjects. Thioredoxin values were higher in patients with MS but did not differ in relation to OLR1 IVS4-14 A>G genotype. The TBARs/Cholesterol ratio was higher in MS both in IVS4-14 GG and in IVS4-14 AG.
CONCLUSION: IVS4-14 GG genotype seems to be related to glucose metabolism disturbance, elevated insulin level and lipid peroxidation in patients with MS.
© 2012 The Authors. European Journal of Clinical Investigation © 2012 Stichting European Society for Clinical Investigation Journal Foundation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23134583     DOI: 10.1111/eci.12013

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  6 in total

1.  LOX-1-Targeted Iron Oxide Nanoparticles Detect Early Diabetic Nephropathy in db/db Mice.

Authors:  Bing Luo; Song Wen; Yu-Chen Chen; Ying Cui; Fa-Bao Gao; Yu-Yu Yao; Sheng-Hong Ju; Gao-Jun Teng
Journal:  Mol Imaging Biol       Date:  2015-10       Impact factor: 3.488

Review 2.  The role of the thioredoxin/thioredoxin reductase system in the metabolic syndrome: towards a possible prognostic marker?

Authors:  Alexey A Tinkov; Geir Bjørklund; Anatoly V Skalny; Arne Holmgren; Margarita G Skalnaya; Salvatore Chirumbolo; Jan Aaseth
Journal:  Cell Mol Life Sci       Date:  2018-01-11       Impact factor: 9.261

3.  Particulate matter from Saudi Arabia induces genes involved in inflammation, metabolic syndrome and atherosclerosis.

Authors:  Jason Brocato; Hong Sun; Magdy Shamy; Thomas Kluz; Mansour A Alghamdi; Mamdouh I Khoder; Lung-Chi Chen; Max Costa
Journal:  J Toxicol Environ Health A       Date:  2014

4.  Association of the LOX-1 rs1050283 Polymorphism with Risk for Atherosclerotic Cerebral Infarction and its Effect on sLOX-1 and LOX-1 Expression in a Chinese Population.

Authors:  Xin Guo; Yuanyuan Xiang; Heng Yang; Lijin Yu; Xiangdong Peng; Ren Guo
Journal:  J Atheroscler Thromb       Date:  2016-11-12       Impact factor: 4.928

5.  Causal network inference from gene transcriptional time-series response to glucocorticoids.

Authors:  Jonathan Lu; Bianca Dumitrascu; Ian C McDowell; Brian Jo; Alejandro Barrera; Linda K Hong; Sarah M Leichter; Timothy E Reddy; Barbara E Engelhardt
Journal:  PLoS Comput Biol       Date:  2021-01-29       Impact factor: 4.475

6.  OLR1 Gene Polymorphism and Oxidized LDL Levels in Metabolic Syndrome in Indian Population.

Authors:  Elvia Jamatia; Pramod Lali; B C Koner; D K Dhanwal; Mirza Masroor; Kritika Krishnamurthy; Aditi Singh
Journal:  Indian J Endocrinol Metab       Date:  2018 Jul-Aug
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.